Current openings at Cajal Therapeutics

Cajal Therapeutics is a Seattle-based biotechnology company dedicated to developing innovative medicines for serious diseases. Our team brings together deep expertise in genetics, computational biology, translational research, and drug development to advance therapies for diseases with high unmet need, including inflammatory anemias and neurodegeneration. Cajal has raised over $130 million to support the progression of our pipeline. Our investors include The Column Group, Lux Capital, Gates Frontier, and Two Sigma Ventures, among others. Backed by this strong syndicate, our multidisciplinary team is working to translate scientific insights into impactful treatments.

Cajal is a team of people first, motivated by our shared mission to bring meaningful therapies to patients. We are committed to ensuring that all our team members feel supported, connected, and energized at work. Our team members eagerly navigate the uncertainty and fast-paced environment of an early-stage biotech company and thrive on getting things done. We value creativity and curiosity in our work, and we take pride in the generosity, sincerity, and kindness of our team members.